Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 2;17(1):243.
doi: 10.1186/s12906-017-1757-5.

Antidiabetic activity and phytochemical screening of extracts of the leaves of Ajuga remota Benth on alloxan-induced diabetic mice

Affiliations

Antidiabetic activity and phytochemical screening of extracts of the leaves of Ajuga remota Benth on alloxan-induced diabetic mice

Tadesse Bekele Tafesse et al. BMC Complement Altern Med. .

Abstract

Background: Ajuga remota Benth is traditionally used in Ethiopia for the management of diabetes mellitus. Since this claim has not been investigated scientifically, the aim of this study was to evaluate the antidiabetic effect and phytochemical screening of the aqueous and 70% ethanol extracts on alloxan-induced diabetic mice.

Methods: After acute toxicity test, the Swiss albino mice were induced with alloxan to get experimental diabetes animals. The fasting mean blood glucose level before and after treatment for two weeks in normal, diabetic untreated and diabetic mice treated with aqueous and 70% ethanol extracts were performed. Data were statistically evaluated by using Statistical Package for the Social Sciences software version 20. P-value <0.05 was considered statistically significant.

Results: The medium lethal doses (LD50) of both extracts were higher than 5000 mg/kg, indicating the extracts are not toxic under the observable condition. Aqueous extracts of A.remota (300 mg/kg and 500 mg/kg body weight) reduced elevated blood glucose levels by 27.83 ± 2.96% and 38.98 ± 0.67% (P < 0.0001), respectively while the 70% ethanol extract caused a reduction of 27.94 ± 1.92% (300 mg/kg) & 28.26 ± 1.82% (500 mg/kg). Treatment with the antidiabetic drug, Glibenclamide (10 mg/kg body weight) lowered blood glucose level by 51.06% (p < 0.05). Phytochemical screening of both extracts indicated the presence of phenolic compounds, flavonoids, saponins, tannins, and steroids, which might contribute to the antidiabetic activity. The extracts, however, did not contain alkaloids and anthraquinones.

Conclusion: The aqueous extract (500 mg/kg) showed the highest percentage reduction in blood glucose levels and the ability of A. remota extracts in reducing blood glucose levels presumably due to the presence of antioxidant constituents such as flavonoids. The effect of the extract supported the traditional claim of the plant.

Keywords: Ajuga Remota; Antidiabetic activity; Blood glucose level; Diabetes mellitus; Glibenclamide; Phytochemical screening.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effect of extracts of A.remota on fasting blood glucose level in normal control and alloxan-induced diabetes mice. AA300: Aqueous Extract of A.remota (300 mg/kg per day); AA500: Aqueous Extract of A.remota (500 mg/kg per day); AE300: 70% Ethanol Extract of A.remota (300 mg/kg per day); AE500: 70% Ethanol Extract A.remota (500 mg/kg per day), NC: Normal Control; DC: Diabetic Control; G10: Glibenclamide (10 mg/kg per day). Data was expressed as mean ± SD (n = 5)
Fig. 2
Fig. 2
Glucose tolerance test of A.remota extracts on alloxan-induced diabetic mice. AA300: Aqueous Extract of A.remota (300 mg/kg per day); AA500: Aqueous Extract of A.remota (500 mg/kg per day); AE300: 70% Ethanol Extract of A.remota (300 mg/kg per day); AE500: 70% Ethanol Extract A.remota (500 mg/kg per day), NC: Normal Control; DC: Diabetic Control; G10: Glibenclamide (10 mg/kg per day). Data was expressed as mean ± SD (n = 5)

Similar articles

Cited by

References

    1. Barcelo A, Rajpathak S. Incidence and prevalence of diabetes mellitus in the Americas. Pan Am J Public Health. 2001;10(5):300–308. doi: 10.1590/S1020-49892001001100002. - DOI - PubMed
    1. International Diabetes Federation (IDF) Diabetes Atlas-7th Edition, 2015. http://www.diabetesatlas.org/resources/2015-atlas.html or (http://www.oedg.at/pdf/1606_IDF_Atlas_2015_UK.pdf).
    1. Rubin R, Strayer DS, Rubin E. Rubin's Pathology: Clinicopathologic Foundations of Medicine, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2012; 1081–1098.
    1. International Diabetes Federation (IDF) Diabetes Atlas-5th Edition, 2012 http://www.indiaenvironmentportal.org.in/files/file/diabetes%20atlas%202...
    1. Koski RR. Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus. The Diabetes Educator. 2006;32(6):869–876. doi: 10.1177/0145721706294260. - DOI - PubMed

MeSH terms